Search results
Results from the WOW.Com Content Network
Lipoatrophy is the term describing the localized loss of fat tissue. This may occur as a result of subcutaneous injections of insulin in the treatment of diabetes , from the use of human growth hormone or from subcutaneous injections of copaxone used for the treatment of multiple sclerosis .
[1] [2] The medical condition is characterized by abnormal or degenerative conditions of the body's adipose tissue. A more specific term, lipoatrophy (from Greek lipo 'fat' and dystrophy 'abnormal or degenerative condition'), is used when describing the loss of fat from one area (usually the face).
This article about an endocrine, nutritional, or metabolic disease is a stub. You can help Wikipedia by expanding it.
Lipoatrophy (loss of fat tissue in specific areas of the body) ... Now, this doesn’t mean that finasteride itself can’t cause side effects. It can and does, although they typically aren’t ...
Medical diagnosis of CGL can be made after observing the physical symptoms of the disease: lipoatrophy (loss of fat tissues) affecting the trunk, limbs, and face; hepatomegaly; acromegaly; insulin resistance; and high serum levels of triglycerides.
Lipoatrophy is the localised loss of fat in tissue. It is common in diabetics who use conventional insulin injection treatment. [ 4 ] In 1949, a much more pure form of insulin was, instead of causing lipoatrophy, shown to regenerate the localised loss of fat after injections in to diabetics. [ 4 ]
This article showcases a curated list of standout studies over the last week on topics such as cholesterol, GLP-1 drugs for weight loss, and supplements for heart health.
Empty-calorie foods and beverages are also calorie-dense, meaning they provide a significant amount of calories per serving (but lack essential nutrients). For example, an orange offers fiber ...